290 related articles for article (PubMed ID: 22275380)
1. HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.
Zhang H; Li H; Xi HS; Li S
Blood; 2012 Mar; 119(11):2595-607. PubMed ID: 22275380
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.
Zhang B; Li M; McDonald T; Holyoake TL; Moon RT; Campana D; Shultz L; Bhatia R
Blood; 2013 Mar; 121(10):1824-38. PubMed ID: 23299311
[TBL] [Abstract][Full Text] [Related]
3. YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m
Chai J; Wang Q; Qiu Q; Han G; Chen Y; Li W; Zhang H
Cell Oncol (Dordr); 2023 Apr; 46(2):451-464. PubMed ID: 36512307
[TBL] [Abstract][Full Text] [Related]
4. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
Wang Z; Chen CC; Chen W
Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
[TBL] [Abstract][Full Text] [Related]
6. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
Jin B; Wang C; Li J; Du X; Ding K; Pan J
Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
[TBL] [Abstract][Full Text] [Related]
7. LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.
Höpner SS; Raykova A; Radpour R; Amrein MA; Koller D; Baerlocher GM; Riether C; Ochsenbein AF
Nat Commun; 2021 Feb; 12(1):1065. PubMed ID: 33594067
[TBL] [Abstract][Full Text] [Related]
8. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
Chen Y; Sullivan C; Peng C; Shan Y; Hu Y; Li D; Li S
Blood; 2011 Jul; 118(2):390-400. PubMed ID: 21596859
[TBL] [Abstract][Full Text] [Related]
9. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
[TBL] [Abstract][Full Text] [Related]
10. Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.
Ng KP; Manjeri A; Lee KL; Huang W; Tan SY; Chuah CT; Poellinger L; Ong ST
Blood; 2014 May; 123(21):3316-26. PubMed ID: 24705490
[TBL] [Abstract][Full Text] [Related]
11. SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
Hansen N; Ågerstam H; Wahlestedt M; Landberg N; Askmyr M; Ehinger M; Rissler M; Lilljebjörn H; Johnels P; Ishiko J; Melo JV; Alexander WS; Bryder D; Järås M; Fioretos T
Leukemia; 2013 Jan; 27(1):130-5. PubMed ID: 22824785
[TBL] [Abstract][Full Text] [Related]
12. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
Cheloni G; Tanturli M; Tusa I; Ho DeSouza N; Shan Y; Gozzini A; Mazurier F; Rovida E; Li S; Dello Sbarba P
Blood; 2017 Aug; 130(5):655-665. PubMed ID: 28576876
[TBL] [Abstract][Full Text] [Related]
13. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
[TBL] [Abstract][Full Text] [Related]
14. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.
Schürch C; Riether C; Matter MS; Tzankov A; Ochsenbein AF
J Clin Invest; 2012 Feb; 122(2):624-38. PubMed ID: 22232214
[TBL] [Abstract][Full Text] [Related]
15. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
16. Single-cell resolution reveals RalA GTPase expanding hematopoietic stem cells and facilitating of BCR-ABL1-driven leukemogenesis in a CRISPR/Cas9 gene editing mouse model.
Yin Z; Su R; Ge L; Wang X; Yang J; Huang G; Li C; Liu Y; Zhang K; Deng L; Fei J
Int J Biol Sci; 2023; 19(4):1211-1227. PubMed ID: 36923939
[TBL] [Abstract][Full Text] [Related]
17. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.
Chen Y; Hu Y; Zhang H; Peng C; Li S
Nat Genet; 2009 Jul; 41(7):783-92. PubMed ID: 19503090
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
Hu Y; Chen Y; Douglas L; Li S
Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
[TBL] [Abstract][Full Text] [Related]
19. Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia.
Zhang H; Li H; Ho N; Li D; Li S
Mol Cell Biol; 2012 May; 32(10):1776-87. PubMed ID: 22431519
[TBL] [Abstract][Full Text] [Related]
20. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
Aljedai A; Buckle AM; Hiwarkar P; Syed F
PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
